You fail to understand two things:
1. The fact remains that Vericel completed a Phase 2b study. Your repeated insistence that they completed three different Phase 2 trials does not change that fact.
2. Where did I say or even imply that primary endpoints were not met? Seriously.
3. No, you have not provided a balanced view and no you don't need to be sorry as it does not bother me one bit.
So knock yourself out with your self-aggrandizing commentary that keeps going off target and is pointless. SMH.
RAT Designation, page-10
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |